AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (519.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Open Access | Just Accepted

Food as a Therapeutic Agent, Antagonist, and Enabler of Pharmacotherapy: A Clinical and Mechanistic Review

Hazem Golshanya,b,c, Zhenhua Lianga,b, Shikang Chena,b, Wenyi Kanga,b ( )

a National R & D Center for Edible Fungus Processing Technology, Henan University, Kaifeng, 475004, China

b College of Agriculture, Henan University, Kaifeng, 475004, China

c Food Science Department, Faculty of Agriculture, Cairo University, 12613 Giza, Egypt

Show Author Information

Abstract

Food intake is usually addressed in pharmacotherapy as a dosing condition or a source of food–drug interactions, yet this view treats food largely as a passive background exposure. To address the separation between therapeutic nutrition and food–drug interaction management, this narrative review proposes a clinically applicable role-based framework that classifies food as a therapeutic agent, an antagonist of pharmacotherapy, or an enabler of treatment according to the dietary exposure, drug and formulation, disease state, timing, and clinical intent. In this framework, food may function as a therapeutic agent, an antagonist of pharmacotherapy, or an enabler of treatment, depending not on the food itself but on the clinical context in which it is consumed. Therapeutic roles include dietary patterns, medically tailored meals, nutrients, and food-derived bioactive compounds that support disease control, symptom relief, nutritional rehabilitation, or treatment responsiveness. Antagonistic roles occur when food reduces efficacy, increases toxicity, or destabilizes response through altered absorption, metabolism, transport, pharmacodynamics, adherence, or food-access constraints. Enabling roles occur when meal timing, composition, or nutritional support increases or stabilizes drug exposure (exposure enablement), reduces gastrointestinal or other treatment-related adverse effects (tolerability enablement), or improves adherence and dosing feasibility (adherence/feasibility enablement). Mechanisms include gastrointestinal physiology, formulation behavior, enzyme and transporter activity, nutrient–drug pharmacodynamics, microbiome effects, and artificial nutrition. Applying this framework requires structured dietary assessment, explicit prescribing instructions, diet-sensitive medication review, and interprofessional care. By classifying food roles conditionally rather than assigning fixed properties to foods, this framework can support more precise prescribing, safer food–drug management, food/formulation design, and patient-centered care.

References

【1】
【1】
 
 
Food Science and Human Wellness

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Golshany H, Liang Z, Chen S, et al. Food as a Therapeutic Agent, Antagonist, and Enabler of Pharmacotherapy: A Clinical and Mechanistic Review. Food Science and Human Wellness, 2026, https://doi.org/10.26599/FSHW.2026.9251254

111

Views

18

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 26 June 2026
Revised: 26 August 2026
Accepted: 04 September 2026
Available online: 30 September 2026

© 2026 Beijing Academy of Food Sciences. Publishing services by Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).